DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine 03.03.2014 / 10:19 --------------------------------------------------------------------- Press Release Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine Berlin, March 3, 2014. The Eckert & Ziegler Abstract Award is entering its seventh year. Young scientists can enter the competition with their innovative scientific research in the field of nuclear medicine. The deadline for submission is April 28, 2014. Each year, the Eckert & Ziegler Abstract Award supports young scientists and PhD students who would like to present their findings to a wider audience at the annual congress of the European Association of Nuclear Medicine (EANM) in October 2014. Five travel grants of EUR 1,000 each will be awarded by Eckert & Ziegler, one of the leading manufacturers of isotope products in Europe, and the European Association of Nuclear Medicine (EANM). The jury consists of a panel of independent, unbiased EANM experts. The five winners will receive their awards on October 22, 2014 at the EANM Annual Congress in Gothenburg, Sweden. Not only are the awards entering their seventh year, they are also gaining increasing popularity in the industry. Last year, almost 600 young scientists from all over the world entered the competition in the hope of winning the coveted award. "Nuclear medicine has huge potential as it can be used to diagnose diseases non-invasively, which would be impossible or very difficult to detect with other methods. It helps patients in terms of early diagnosis and in deciding on a targeted therapy. This is why we hope to help ensure with these awards that the substantial progress in medical imaging can soon be transformed into more precise, faster or less expensive methods of diagnosis and therapy," commented Karolin Riehle, spokeswoman for Eckert & Ziegler AG. Eligibility for Participation All EANM members who are not older than 38 years of age at the time of submission are eligible to participate. Applications can be submitted electronically at http://eanm14.eanm.org. The submission deadline is April 28, 2014. Eckert & Ziegler The Eckert & Ziegler Group (ISIN DE0005659700), with approximately 700 employees, is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine. Eckert & Ziegler supports the widespread use of PET/CT hybrid systems by expanding its production sites for radioactive contrast agents and by developing automated synthesis modules in which scientists can produce new diagnostic substances with the requisite pharmaceutical quality. For further information, please contact: Eckert & Ziegler AG, Karolin Riehle, Public Relations Robert-Rössle-Str. 10, D-13125 Berlin, Tel.: +49 (0) 30 / 941084-138 Email: [email protected], www.ezag.de End of Corporate News --------------------------------------------------------------------- 03.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: [email protected] Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, München End of News DGAP News-Service --------------------------------------------------------------------- 255348 03.03.2014